Among them, Bruton’s tyrosine kinase (BTK) and phosphoinositide 3-kinase (PI3K) inhibitors have exhibited encouraging effects on human and canine leukemia and lymphoma. The gene discussed is PIK3CA; the disease is lymphoma.